Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Bone marrow blasts"'
Autor:
Nahla Abdel Moneim Hamed, Nabil El Halawani, Dalia Nafea, Mohamed Abd El Rahman, Ahmed Kasber
Publikováno v:
Acta Medica International, Vol 4, Iss 1, Pp 51-55 (2017)
Objective: to study soluble HLA-G (sHLA-G) in Egyptian acute myeloid leukemia (AML) patients. HLA-G is speculated to be a tumor-driven immune escape mechanism. In addition, it might be a promising target for future immune therapeutic approaches. Meth
Externí odkaz:
https://doaj.org/article/253094c24fc84fdd8140ab060a108c10
Autor:
Anıl Tombak, Mehmet Ali Uçar, Aydan Akdeniz, Eyüp Naci Tiftik, Deniz Gören Şahin, Olga Meltem Akay, Murat Yıldırım, Oral Nevruz, Cem Kis, Emel Gürkan, Şerife Medeni Solmaz, Mehmet Ali Özcan, Rahşan Yıldırım, İlhami Berber, Mehmet Ali Erkurt, Tülin Fıratlı Tuğlular, Pınar Tarkun, İrfan Yavaşoğlu, Mehmet Hilmi Doğu, İsmail Sarı, Mustafa Merter, Muhit Özcan, Esra Yıldızhan, Leylagül Kaynar, Özgür Mehtap, Ayşe Uysal, Fahri Şahin, Ozan Salim, Mehmet Ali Sungur
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 4, Pp 273-280 (2016)
Objective: In this study, we aimed to investigate the efficacy and safety of azacitidine (AZA) in elderly patients with acute myeloid leukemia (AML), including patients with >30% bone marrow (BM) blasts. Materials and Methods: In this retrospective m
Externí odkaz:
https://doaj.org/article/991999bdfbb345eea13143fc24d2544e
Autor:
Josef Thaler, Richard Greil, Wolfgang R. Sperr, Sigrid Machherndl-Spandl, Martin Schreder, Otto Eckmüllner, Daniela Voskova, Werner Linkesch, Dietmar Geissler, Peter Krippl, Christoph Tinchon, Michael Girschikofsky, Thamer Sliwa, Alois Lang, Lisa Pleyer, Sonja Burgstaller, Konstantin Schlick, Georg Theiler, Michael Pfeilstöcker, Reinhard Stauder
Publikováno v:
Annals of Hematology
Data on efficacy and safety of azacitidine in acute myeloid leukemia (AML) with >30 % bone marrow (BM) blasts are limited, and the drug can only be used off-label in these patients. We previously reported on the efficacy and safety of azacitidine in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ba678259f89aa57b6988ee9d9c5f7ad
http://europepmc.org/articles/PMC4176957
http://europepmc.org/articles/PMC4176957
Autor:
J S, Jia, S M, Yang, J, Wang, H, Jiang, T, Zhao, L, Bao, H X, Shi, J, Lu, H H, Zhu, Y Y, Lai, B, Jiang, X J, Huang, Q, Jiang
Publikováno v:
Chinese Journal of Hematology
To investigate the prognostic significance of proportion of the blasts in bone marrow on day 14 (D14) during induction chemotherapy in patients with adult Ph-negative acute lymphoblastic leukemia (Ph (-) ALL).Newly diagnosed Ph (-) ALL patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::98e262de5943d3fd7ac821d76c3e5d57
https://pubmed.ncbi.nlm.nih.gov/27431075
https://pubmed.ncbi.nlm.nih.gov/27431075
Autor:
Mustafa Merter, Aydan Akdeniz, Mehmet Ali Özcan, Ozan Salim, Mehmet Ali Sungur, Rahsan Yildirim, Oral Nevruz, Anil Tombak, Fahri Şahin, Özgür Mehtap, Cem Kis, Mehmet Hilmi Dogu, Eyup Naci Tiftik, Mehmet Ali Ucar, Olga Meltem Akay, Mehmet Ali Erkurt, Muhit Ozcan, Esra Yildizhan, Murat Yıldırım, Irfan Yavasoglu, Tulin Firatli Tuglular, Deniz Goren Sahin, Pinar Tarkun, Ayşe Uysal, Leylagül Kaynar, Emel Gürkan, Ismail Sari, Ilhami Berber, Şerife Solmaz
Publikováno v:
Turkish Journal of Hematology
Turkish Journal of Hematology, Vol 33, Iss 4, Pp 273-280 (2016)
Turkish Journal of Hematology, Vol 33, Iss 4, Pp 273-280 (2016)
WOS: 000392282500002
PubMed ID: 27095141
Objective: In this study, we aimed to investigate the efficacy and safety of azacitidine (AZA) in elderly patients with acute myeloid leukemia (AML), including patients with >30% bone marrow (BM) bla
PubMed ID: 27095141
Objective: In this study, we aimed to investigate the efficacy and safety of azacitidine (AZA) in elderly patients with acute myeloid leukemia (AML), including patients with >30% bone marrow (BM) bla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dd4ebfc9fdea805a63c0c6ec11a7686
https://hdl.handle.net/20.500.12684/5162
https://hdl.handle.net/20.500.12684/5162
PubMedID: 27095141 Objective: In this study, we aimed to investigate the efficacy and safety of azacitidine (AZA) in elderly patients with acute myeloid leukemia (AML), including patients with >30% bone marrow (BM) blasts. Materials and Methods: In t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______9491::687dca58879b2cc51fc2aff456f96d06
https://hdl.handle.net/20.500.12605/21844
https://hdl.handle.net/20.500.12605/21844
Autor:
Tombak, A, Ucar, MA, Akdeniz, A, Tiftik, EN, Sahin, DG, Akay, OM, Yildirim, M, Nevruz, O, Kis, C, Gurkan, E, Solmaz, SM, Ozcan, MA, Yildirim, R, Berber, I, Erkurt, MA, Tuglular, TF, Tarkun, P, Yavasoglu, I, Dogu, MH, Sari, I, Merter, M, Ozcan, M, Yildizhan, E, Kaynar, L, Mehtap, O, Uysal, A, Sahin, F, Salim, O, Sungur, MA
Objective: In this study, we aimed to investigate the efficacy and safety of azacitidine (AZA) in elderly patients with acute myeloid leukemia (AML), including patients with >30% bone marrow (BM) blasts. Materials and Methods: In this retrospective m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::232de2fba34fd0c1f2de8d3f84ab2727
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/23377
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/23377
Autor:
Mohamed Abd El Rahman, Nahla Abdel Moneim Hamed, Nabil A El Halawani, Dalia A. Nafea, Ahmed Kasber
Publikováno v:
Acta Medica International, Vol 4, Iss 1, Pp 51-55 (2017)
Objective: to study soluble HLA-G (sHLA-G) in Egyptian acute myeloid leukemia (AML) patients. HLA-G is speculated to be a tumor-driven immune escape mechanism. In addition, it might be a promising target for future immune therapeutic approaches. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28365eca69ef0de94e5d2a4ba6070823
https://doi.org/10.5530/ami.2017.4.10
https://doi.org/10.5530/ami.2017.4.10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.